Monoamine reuptake inhibitors for treatment of cns disorders

Details Monoamine reuptake inhibitors for treatment of cns disorders Monoamine reuptake inhibitors for treatment of cns disorders

C - Chemistry, Metallurgy

07

C

C07C 217/58 (2006.01) A61K 31/135 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) C07C 217/90 (2006.01) C07C 235/34 (2006.01) C07C 255/37 (2006.01) C07C 255/59 (2006.01) C07C 311/29 (2006.01) C07C 323/20 (2006.01) C07D 207/08 (2006.01) C07D 211/22 (2006.01) C07D 265/30 (2006.01) C07D 279/12 (2006.01)

Patent

CA 2364718

The present invention relates to compounds that are a useful exhibit activity as serotonin, norepinephrine and dopamine reuptake inhibitors, and their pharmaceutically acceptable salts, and their use in the treatment of central nervous system and other disorders.

La présente invention concerne des composés possédant une activité utile comme inhibiteurs de recaptage de sérotonine, de noradrénaline et de dopamine, ainsi que leurs sels acceptables au plan pharmaceutique et leur utilisation dans le traitement de troubles du système nerveux central et d'autres troubles.

Affiliated with

Also associated with

Rating

Monoamine reuptake inhibitors for treatment of cns disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoamine reuptake inhibitors for treatment of cns disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoamine reuptake inhibitors for treatment of cns disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1601073